Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
6.52
+2.91 (80.61%)
At close: Mar 6, 2026, 4:00 PM EST
6.53
+0.01 (0.15%)
After-hours: Mar 6, 2026, 7:59 PM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $54.43 million as of March 6, 2026. Its market cap has increased by 208.94% in one year.
Market Cap
54.43M
Enterprise Value
42.38M
1-Year Change
208.94%
Ranking
Category
Stock Price
$6.52
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $54.43M, an increase of 46.64%. That is a compound annual growth rate of 5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 30.14M | 154.66% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 38.02M |
| INmune Bio | 37.22M |
| Jasper Therapeutics | 37.22M |
| CervoMed | 37.10M |
| Tvardi Therapeutics | 36.96M |
| Sensei Biotherapeutics | 36.70M |
| PDS Biotechnology | 36.50M |
| Pluri | 35.48M |